Stephen Troum, MD
Surgery of the Hand · Southlake, TXNPI 1841298007
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,125 of the $2,900 with a category attached, or 73.3%. Osteomed LLC accounts for 73.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $2,400 and has fallen 86.5% since, to $325 in 2025.
Across 19 payments — averaging $152.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$2K
- Smith+Nephew$143
- Skeletal Dynamics Inc$118
- Highridge Medical LLC$108
- Medartis Inc.$81
- EBI, LLC$77
- plus $248 from 7 others
What the payments were for
- Consulting fees$2,12573%
- Food & beverage$77527%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 2 | $2,125 |
| Smith+Nephew | 2 | $143 |
| Skeletal Dynamics Inc | 1 | $118 |
| Highridge Medical LLC | 2 | $108 |
| Medartis Inc. | 1 | $81 |
| EBI, LLC | 1 | $77 |
| Johnson & Johnson | 2 | $67 |
| Integra Lifesciences Corporation | 2 | $60 |
| Orthofix Medical, Inc. | 2 | $32 |
| Amgen | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Zyla Life Sciences, Inc. | 1 | $24 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,900 in reported general payments places this provider in the 60th percentile of 68 surgery of the hand providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $326 |
| Meloxicam | 70 | $231 |
| Celecoxib | 13 | $222 |
| Tramadol Hcl | 44 | $116 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Southlake
- Desirae McKeeLubbock$59K
- Stuart HilliardDenton$21K
- Harrison KayAustin$19K
- Suresh KoneruSan Antonio$17K
- Dustin RayDallas$15K
- Laurence WeiderDallas$13K
- Andrew ZhangDallas$11K
- James HovisArlington$11K
- James LinSpring$10K
- Michael JonesSan Antonio$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.